Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 8/20 | 0.39 |
| ▸ | CA2 | P00918 | 8/20 | 0.39 |
| ▸ | CA9 | Q16790 | 7/20 | 0.39 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | CA7 | P43166 | 3/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.39 |
| ▸ | CA3 | P07451 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | CA6 | P23280 | 2/20 | 0.39 |
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.39 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.38 |
| ▸ | PRKCG | P05129 | 1/20 | 0.38 |
| ▸ | PRKCB | P05771 | 1/20 | 0.38 |
| ▸ | PRKCA | P17252 | 1/20 | 0.38 |
| ▸ | PRKCH | P24723 | 1/20 | 0.38 |
| ▸ | PRKCI | P41743 | 1/20 | 0.38 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.38 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15384178 | 1.00 | DNM1 (0.47) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL26986860 | 0.91 | ADRB2 (0.36) | DNM1CA1CA2TSHR | |
| SCHEMBL438937 | 0.91 | ADRB2 (0.36) | DNM1CA1CA2TSHR | |
| SCHEMBL13038625 | 0.88 | DNM1 (0.52) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL27058279 | 0.88 | DNM1 (0.52) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL24562854 | 0.88 | DNM1 (0.52) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL28878262 | 0.88 | DNM1 (0.52) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL14836599 | 0.84 | DNM1 (0.48) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL27433788 | 0.83 | DNM1 (0.44) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL27835501 | 0.82 | DNM1 (0.47) | DNM1CA1CA2CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080071084-A1 | Using an alcohol in presence of copper catalyst and ligand | ARCHIMICA GMBH (DE) | 2008-03-20 | — | — | US | claimed |
| US-20080071084-A1 | Using an alcohol in presence of copper catalyst and ligand | ARCHIMICA GMBH (DE) | 2008-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080071084-A1 | Using an alcohol in presence of copper catalyst and ligand | NR1H3, NR1H2, ADH1A | DNM1 2704/4885CA1 900/4885CA2 3567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.